Antimicrobial Resistance: What’s At Stake And What Are We Doing About It? | Health Affairs

CEID Faculty Dr. Kevin Outterson and co-authors offer insights about Antimicrobial Resistance (AMR), concluding that:

“The antibacterial market is broken. More than a decade of incremental reforms has been helpful, but serious problems remain. Policy makers now have the opportunity to fundamentally reform the sector through delinked pull incentives such as the subscription program in the proposed PASTEUR Act. Strong support for innovation, stewardship, and access are required.”

Read the full article here.